Answers are grounded in this paper and cite their sources.
Review highlights diagnostic and therapeutic advancements in patients with Alzheimer's disease, suggesting artificial intelligence and theranostics will guide future care.
Biomarkers, brain-imaging, and theranostics, along with artificial intelligence, are understood to be the future of the management of Alzheimer's.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: